607 related articles for article (PubMed ID: 33921556)
1. Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes.
Valenza M; Facchinetti R; Menegoni G; Steardo L; Scuderi C
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921556
[TBL] [Abstract][Full Text] [Related]
2. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
3. Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease.
Yi C; Koulakoff A; Giaume C
Curr Pharm Des; 2017; 23(33):4958-4968. PubMed ID: 28982320
[TBL] [Abstract][Full Text] [Related]
4. Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin.
Facchinetti R; Valenza M; Bronzuoli MR; Menegoni G; Ratano P; Steardo L; Campolongo P; Scuderi C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471239
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
Bronzuoli MR; Facchinetti R; Steardo L; Romano A; Stecca C; Passarella S; Steardo L; Cassano T; Scuderi C
Oxid Med Cell Longev; 2018; 2018():4720532. PubMed ID: 29576849
[TBL] [Abstract][Full Text] [Related]
7. The contribution of astrocytes to Alzheimer's disease.
Birch AM
Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
[TBL] [Abstract][Full Text] [Related]
8. S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer's Disease.
Cirillo C; Capoccia E; Iuvone T; Cuomo R; Sarnelli G; Steardo L; Esposito G
Biomed Res Int; 2015; 2015():508342. PubMed ID: 26295040
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte subtype-specific approach to Alzheimer's disease treatment.
Sarkar S; Biswas SC
Neurochem Int; 2021 May; 145():104956. PubMed ID: 33503465
[TBL] [Abstract][Full Text] [Related]
10. Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.
Osborn LM; Kamphuis W; Wadman WJ; Hol EM
Prog Neurobiol; 2016 Sep; 144():121-41. PubMed ID: 26797041
[TBL] [Abstract][Full Text] [Related]
11. Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease.
Lan YL; Chen JJ; Hu G; Xu J; Xiao M; Li S
Curr Pharm Des; 2017; 23(33):4948-4957. PubMed ID: 28714415
[TBL] [Abstract][Full Text] [Related]
12. Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective.
Suidan GL; Ramaswamy G
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052389
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
Pilipenko V; Narbute K; Pupure J; Rumaks J; Jansone B; Klusa V
Neuropharmacology; 2019 Jan; 144():319-326. PubMed ID: 30408486
[TBL] [Abstract][Full Text] [Related]
14. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease.
Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C
Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977
[TBL] [Abstract][Full Text] [Related]
15. The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease.
Fontana IC; Kumar A; Nordberg A
Nat Rev Neurol; 2023 May; 19(5):278-288. PubMed ID: 36977843
[TBL] [Abstract][Full Text] [Related]
16. Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity.
Toral-Rios D; Patiño-López G; Gómez-Lira G; Gutiérrez R; Becerril-Pérez F; Rosales-Córdova A; León-Contreras JC; Hernández-Pando R; León-Rivera I; Soto-Cruz I; Florán-Garduño B; Campos-Peña V
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050466
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.
Martins RN; Taddei K; Kendall C; Evin G; Bates KA; Harvey AR
Neuroscience; 2001; 106(3):557-69. PubMed ID: 11591456
[TBL] [Abstract][Full Text] [Related]
18. P38K and JNK pathways are induced by amyloid-β in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease.
Saha P; Guha S; Biswas SC
Mol Cell Neurosci; 2020 Oct; 108():103551. PubMed ID: 32896578
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
[TBL] [Abstract][Full Text] [Related]
20. Reactive astrocytes in Alzheimer's disease: A double-edged sword.
Chun H; Lee CJ
Neurosci Res; 2018 Jan; 126():44-52. PubMed ID: 29225140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
